PF-04360365

BIOLOGICAL3 trials

Sponsors

Pfizer

Conditions

Alzheimer's Disease

Phase 1

A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease

CompletedNCT00455000

PfizerAlzheimer's Disease

Start: 2007-03-31End: 2009-09-30Updated: 2009-10-14

A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

CompletedNCT00607308

PfizerAlzheimer's Disease

Start: 2008-02-29End: 2010-10-31Updated: 2010-12-07

Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers

CompletedNCT01005862

PfizerAlzheimer's Disease

Start: 2010-03-31End: 2012-09-30Updated: 2012-09-26